Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Gender on ED50 of remimazolam + sufentanil for endotracheal intubation in elderly hepatectomy patients
ChiCTR2200065725Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and sufentanil in None (2 cohorts), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Successful endotracheal intubation. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remimazolamsufentanil
Beyond the preview
Go deeper on ChiCTR2200065725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065725.